2023 FDA approvals

被引：32
|
作者：
Asher Mullard
机构：
来源：
Nature Reviews Drug Discovery | 2024年 / 23卷 / 2期
关键词：
D O I：
10.1038/d41573-024-00001-x
中图分类号：
学科分类号：
摘要：
The FDA approved 55 novel therapeutics in 2023, the second highest count in the past 30 years.
引用
收藏
页码：88 / 95
页数：7
相关论文
共 50 条
  • [1] 2023 FDA approvals in gastroenterology and hepatology
    Kotsiliti, Eleni
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2024, 21 (04) : 219 - 219
  • [2] 2023 FDA approvals in gastroenterology and hepatology
    Eleni Kotsiliti
    [J]. Nature Reviews Gastroenterology & Hepatology, 2024, 21 : 219 - 219
  • [3] 2023 in review: FDA approvals of new medicines
    Kinch, Michael S.
    Kraft, Zachary
    Schwartz, Tyler
    [J]. DRUG DISCOVERY TODAY, 2024, 29 (05)
  • [4] Targeted drug approvals in 2023: breakthroughs by the FDA and NMPA
    Zheng, Lang
    Wang, Wenjing
    Sun, Qiu
    [J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
  • [5] 2023 FDA approvals: unprecedented volume at moderate value
    Baedeker, Mathias
    Ringel, Michael S.
    Moeller, Clemens C.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2024, 23 (02) : 98 - 98
  • [6] Targeted drug approvals in 2023: breakthroughs by the FDA and NMPA
    Lang Zheng
    Wenjing Wang
    Qiu Sun
    [J]. Signal Transduction and Targeted Therapy, 9
  • [7] 2023 FDA approvals: unprecedented volume at moderate value
    Mathias Baedeker
    Michael S. Ringel
    Clemens C. Möller
    [J]. Nature Reviews Drug Discovery, 2024, 23 : 98 - 98
  • [8] FDA new drug approvals in Q2 2023
    Urquhart, Lisa
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2023, 22 (08) : 614 - 614
  • [9] Food and Drug Administration (FDA) Approvals of Biological Drugs in 2023
    Martins, Alexander C.
    Oshiro, Mariana Y.
    Albericio, Fernando
    de la Torre, Beatriz G.
    [J]. BIOMEDICINES, 2024, 12 (09)
  • [10] FDA new drug approvals in Q2 2023
    Lisa Urquhart
    [J]. Nature Reviews Drug Discovery, 2023, 22 : 614 - 614
12345